Skip to main content
Premium Trial:

Request an Annual Quote

Dutch Seed Firm Bejo Takes License to Corteva Agriscience, Broad Institute CRISPR IP

NEW YORK — Dutch vegetable seed firm Bejo said this week that it has acquired a nonexclusive license to CRISPR-Cas9 intellectual property from Corteva Agriscience and the Broad Institute.

Under the terms of the license, Bejo can use the IP in its agriculture research and commercial programs. The company noted, however, that it will use the genome-editing technology for research only pending changes in legislation.

"Gene editing technologies like CRISPR-Cas9 bring opportunities for accelerating Bejo's vegetable breeding programs," Bert Schrijver, director of R&D at Bejo, said in a statement. "They increase our understanding of genetics and provide tools to develop new traits such as abiotic stress and disease resistance."

In 2017, DowDuPont — which spun off its agriculture business as Corteva in 2019 — and the Broad Institute agreed to jointly offer nonexclusive licenses to their respective CRISPR-Cas9 IP for commercial agricultural research and product development. Licensees of the technology include Yield10 and Amfora.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.